Commit To Buy Nektar Therapeutics At $13, Earn 11.1% Annualized Using Options
July 29, 2016 at 11:43 AM EDT
Investors considering a purchase of Nektar Therapeutics (NKTR) stock, but tentative about paying the going market price of $16.60/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2017 put at the $13 strike, which has a bid at the time of this writing of 80 cents..